Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Upgrades
For Tabula Rasa HealthCare Inc (NASDAQ:TRHC), SVB Leerink upgraded the previous rating of Market Perform to Outperform. Tabula Rasa HealthCare earned $0.02 in the first quarter, compared to $0.68 in the year-ago quarter. The current stock performance of Tabula Rasa HealthCare shows a 52-week-high of $6.69 and a 52-week-low of $2.09. Moreover, at the end of the last trading period, the closing price was at $5.52.
According to Maxim Group, the prior rating for Paltalk Inc (NASDAQ:PALT) was changed from Hold to Buy. Paltalk earned $0.08 in the first quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Paltalk shows a 52-week-high of $4.60 and a 52-week-low of $1.28. Moreover, at the end of the last trading period, the closing price was at $2.26.
According to Northland Capital Markets, the prior rating for Vitesse Energy Inc (NYSE:VTS) was changed from Market Perform to Outperform. In the first quarter, Vitesse Energy showed an EPS of $0.53, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $20.99 and a 52-week-low of $13.90. At the end of the last trading period, Vitesse Energy closed at $18.71.
For Jack In The Box Inc (NASDAQ:JACK), OTR Global upgraded the previous rating of Mixed to Positive. In the first quarter, Jack In The Box showed an EPS of $2.01, compared to $1.97 from the year-ago quarter. The stock has a 52-week-high of $94.93 and a 52-week-low of $54.86. At the end of the last trading period, Jack In The Box closed at $92.61.
Craig-Hallum upgraded the previous rating for GrowGeneration Corp (NASDAQ:GRWG) from Hold to Buy. GrowGeneration earned $0.10 in the first quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $8.62 and a 52-week-low of $2.77. At the end of the last trading period, GrowGeneration closed at $3.70.
For Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), Oppenheimer upgraded the previous rating of Perform to Outperform. Corbus Pharmaceuticals earned $4.24 in the first quarter, compared to $2.40 in the year-ago quarter. The stock has a 52-week-high of $13.17 and a 52-week-low of $2.11. At the end of the last trading period, Corbus Pharmaceuticals closed at $8.87.
For Albemarle Corp (NYSE:ALB), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the first quarter, Albemarle showed an EPS of $10.32, compared to $2.38 from the year-ago quarter. At the moment, the stock has a 52-week-high of $334.20 and a 52-week-low of $171.82. Albemarle closed at $195.17 at the end of the last trading period.
B of A Securities upgraded the previous rating for Celsius Holdings Inc (NASDAQ:CELH) from Neutral to Buy. Celsius Holdings earned $0.40 in the first quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Celsius Holdings shows a 52-week-high of $122.24 and a 52-week-low of $38.38. Moreover, at the end of the last trading period, the closing price was at $107.12.
According to B of A Securities, the prior rating for InterDigital Inc (NASDAQ:IDCC) was changed from Underperform to Buy. InterDigital earned $4.21 in the first quarter, compared to $0.58 in the year-ago quarter. The stock has a 52-week-high of $81.95 and a 52-week-low of $40.24. At the end of the last trading period, InterDigital closed at $80.00.
According to Craig-Hallum, the prior rating for Quotient Technology Inc (NYSE:QUOT) was changed from Hold to Buy. For the first quarter, Quotient Technology had an EPS of $0.18, compared to year-ago quarter EPS of $0.28. At the moment, the stock has a 52-week-high of $4.56 and a 52-week-low of $1.68. Quotient Technology closed at $2.90 at the end of the last trading period.
Craig-Hallum upgraded the previous rating for Exact Sciences Corp (NASDAQ:EXAS) from Hold to Buy. For the first quarter, Exact Sciences had an EPS of $0.42, compared to year-ago quarter EPS of $1.04. The stock has a 52-week-high of $72.19 and a 52-week-low of $29.29. At the end of the last trading period, Exact Sciences closed at $71.00.
For MasterBrand Inc (NYSE:MBC), Loop Capital upgraded the previous rating of Hold to Buy. For the first quarter, MasterBrand had an EPS of $0.28, compared to year-ago quarter EPS of $0.40. The current stock performance of MasterBrand shows a 52-week-high of $10.21 and a 52-week-low of $7.08. Moreover, at the end of the last trading period, the closing price was at $8.64.
For Y-mAbs Therapeutics Inc (NASDAQ:YMAB), Wedbush upgraded the previous rating of Neutral to Outperform. For the first quarter, Y-mAbs Therapeutics had an EPS of $0.15, compared to year-ago quarter EPS of $0.64. At the moment, the stock has a 52-week-high of $20.31 and a 52-week-low of $2.70. Y-mAbs Therapeutics closed at $9.23 at the end of the last trading period.
Jefferies upgraded the previous rating for Nektar Therapeutics (NASDAQ:NKTR) from Underperform to Hold. For the first quarter, Nektar Therapeutics had an EPS of $0.25, compared to year-ago quarter EPS of $0.49. At the moment, the stock has a 52-week-high of $5.17 and a 52-week-low of $0.60. Nektar Therapeutics closed at $0.77 at the end of the last trading period.
Itau BBA upgraded the previous rating for Vtex (NYSE:VTEX) from Market Perform to Outperform. In the first quarter, Vtex showed an EPS of $0.04, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $5.43 and a 52-week-low of $2.69. At the end of the last trading period, Vtex closed at $3.60.
For Alcon Inc (NYSE:ALC), Baird upgraded the previous rating of Neutral to Outperform. Alcon earned $0.70 in the first quarter, compared to $0.68 in the year-ago quarter. The stock has a 52-week-high of $78.55 and a 52-week-low of $55.21. At the end of the last trading period, Alcon closed at $74.31.
According to Piper Sandler, the prior rating for Halozyme Therapeutics Inc (NASDAQ:HALO) was changed from Neutral to Overweight. For the first quarter, Halozyme Therapeutics had an EPS of $0.47, compared to year-ago quarter EPS of $0.47. The current stock performance of Halozyme Therapeutics shows a 52-week-high of $59.45 and a 52-week-low of $29.85. Moreover, at the end of the last trading period, the closing price was at $30.58.
For The Hain Celestial Group Inc (NASDAQ:HAIN), Piper Sandler upgraded the previous rating of Underweight to Neutral. For the third quarter, Hain Celestial Group had an EPS of $0.08, compared to year-ago quarter EPS of $0.33. The current stock performance of Hain Celestial Group shows a 52-week-high of $28.13 and a 52-week-low of $15.20. Moreover, at the end of the last trading period, the closing price was at $15.42.
See all analyst ratings upgrades.
Downgrades
According to Alliance Global Partners, the prior rating for Aterian Inc (NASDAQ:ATER) was changed from Buy to Neutral. For the first quarter, Aterian had an EPS of $0.13, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $4.38 and a 52-week-low of $0.67. At the end of the last trading period, Aterian closed at $0.78.
For Innovative Industrial Properties Inc (NYSE:IIPR), Craig-Hallum downgraded the previous rating of Buy to Hold. In the first quarter, Innovative Ind Props showed an EPS of $2.25, compared to $2.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of $139.69 and a 52-week-low of $63.36. Innovative Ind Props closed at $71.43 at the end of the last trading period.
Edward Jones downgraded the previous rating for PayPal Holdings Inc (NASDAQ:PYPL) from Buy to Hold. For the first quarter, PayPal Holdings had an EPS of $1.17, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $103.02 and a 52-week-low of $65.85. At the end of the last trading period, PayPal Holdings closed at $65.91.
According to JP Morgan, the prior rating for Dutch Bros Inc (NYSE:BROS) was changed from Overweight to Neutral. For the first quarter, Dutch Bros had an EPS of $0.00, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $54.13 and a 52-week-low of $20.07. Dutch Bros closed at $32.45 at the end of the last trading period.
For Health Catalyst Inc (NASDAQ:HCAT), Raymond James downgraded the previous rating of Strong Buy to Market Perform. For the first quarter, Health Catalyst had an EPS of $0.05, compared to year-ago quarter EPS of $0.06. The stock has a 52-week-high of $18.28 and a 52-week-low of $6.41. At the end of the last trading period, Health Catalyst closed at $11.95.
Guggenheim downgraded the previous rating for Health Catalyst Inc (NASDAQ:HCAT) from Buy to Hold. In the first quarter, Health Catalyst showed an EPS of $0.05, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $18.28 and a 52-week-low of $6.41. At the end of the last trading period, Health Catalyst closed at $11.95.
TD Cowen downgraded the previous rating for Dutch Bros Inc (NYSE:BROS) from Outperform to Market Perform. Dutch Bros earned $0.00 in the first quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $54.13 and a 52-week-low of $20.07. At the end of the last trading period, Dutch Bros closed at $32.45.
According to Raymond James, the prior rating for Wheels Up Experience Inc (NYSE:UP) was changed from Outperform to Market Perform. In the first quarter, Wheels Up Experience showed an EPS of $0.31, compared to $0.25 from the year-ago quarter. The stock has a 52-week-high of $2.88 and a 52-week-low of $0.37. At the end of the last trading period, Wheels Up Experience closed at $0.39.
According to William Blair, the prior rating for Amplitude Inc (NASDAQ:AMPL) was changed from Outperform to Market Perform. Amplitude earned $0.04 in the first quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Amplitude shows a 52-week-high of $19.71 and a 52-week-low of $10.51. Moreover, at the end of the last trading period, the closing price was at $11.63.
According to Jefferies, the prior rating for Prometheus Biosciences Inc (NASDAQ:RXDX) was changed from Buy to Hold. Prometheus Biosciences earned $0.86 in the first quarter, compared to $0.82 in the year-ago quarter. The stock has a 52-week-high of $197.83 and a 52-week-low of $21.57. At the end of the last trading period, Prometheus Biosciences closed at $194.40.
Rosenblatt downgraded the previous rating for Bentley Systems Inc (NASDAQ:BSY) from Buy to Neutral. Bentley Systems earned $0.25 in the first quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $46.97 and a 52-week-low of $26.33. Bentley Systems closed at $46.31 at the end of the last trading period.
According to Deutsche Bank, the prior rating for AdaptHealth Corp (NASDAQ:AHCO) was changed from Buy to Hold. In the first quarter, AdaptHealth showed an EPS of $0.06, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $27.48 and a 52-week-low of $10.21. At the end of the last trading period, AdaptHealth closed at $11.30.
According to Barclays, the prior rating for Lumentum Holdings Inc (NASDAQ:LITE) was changed from Overweight to Equal-Weight. In the third quarter, Lumentum Holdings showed an EPS of $0.75, compared to $1.19 from the year-ago quarter. The stock has a 52-week-high of $96.45 and a 52-week-low of $44.94. At the end of the last trading period, Lumentum Holdings closed at $45.99.
According to BMO Capital, the prior rating for Expensify Inc (NASDAQ:EXFY) was changed from Outperform to Market Perform. For the first quarter, Expensify had an EPS of $0.05, compared to year-ago quarter EPS of $0.09. The current stock performance of Expensify shows a 52-week-high of $25.36 and a 52-week-low of $7.01. Moreover, at the end of the last trading period, the closing price was at $7.24.
For Southern Copper Corp (NYSE:SCCO), Goldman Sachs downgraded the previous rating of Neutral to Sell. In the fourth quarter, Southern Copper showed an EPS of $1.17, compared to $1.08 from the year-ago quarter. The stock has a 52-week-high of $82.05 and a 52-week-low of $42.49. At the end of the last trading period, Southern Copper closed at $79.04.
BTIG downgraded the previous rating for Wheels Up Experience Inc (NYSE:UP) from Buy to Neutral. Wheels Up Experience earned $0.31 in the first quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $2.88 and a 52-week-low of $0.37. At the end of the last trading period, Wheels Up Experience closed at $0.39.
Morgan Stanley downgraded the previous rating for Sealed Air Corp (NYSE:SEE) from Overweight to Equal-Weight. For the first quarter, Sealed Air had an EPS of $0.74, compared to year-ago quarter EPS of $1.12. At the moment, the stock has a 52-week-high of $65.96 and a 52-week-low of $41.15. Sealed Air closed at $42.64 at the end of the last trading period.
For Nikola Corp (NASDAQ:NKLA), TD Cowen downgraded the previous rating of Outperform to Market Perform. Nikola earned $0.26 in the first quarter, compared to $0.21 in the year-ago quarter. The current stock performance of Nikola shows a 52-week-high of $8.97 and a 52-week-low of $0.79. Moreover, at the end of the last trading period, the closing price was at $0.86.
According to Stifel, the prior rating for AdaptHealth Corp (NASDAQ:AHCO) was changed from Buy to Hold. AdaptHealth earned $0.06 in the first quarter, compared to $0.08 in the year-ago quarter. The current stock performance of AdaptHealth shows a 52-week-high of $27.48 and a 52-week-low of $10.21. Moreover, at the end of the last trading period, the closing price was at $11.30.
According to Piper Sandler, the prior rating for Amplitude Inc (NASDAQ:AMPL) was changed from Overweight to Neutral. Amplitude earned $0.04 in the first quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Amplitude shows a 52-week-high of $19.71 and a 52-week-low of $10.51. Moreover, at the end of the last trading period, the closing price was at $11.63.
See all analyst ratings downgrades.
Initiations
Truist Securities initiated coverage on Voyager Therapeutics Inc (NASDAQ:VYGR) with a Buy rating. The price target for Voyager Therapeutics is set to $18.00. In the first quarter, Voyager Therapeutics showed an EPS of $2.94, compared to $0.56 from the year-ago quarter. The current stock performance of Voyager Therapeutics shows a 52-week-high of $11.49 and a 52-week-low of $4.61. Moreover, at the end of the last trading period, the closing price was at $10.76.
With a Equal-Weight rating, Barclays initiated coverage on Pacific Biosciences of California Inc (NASDAQ:PACB). The price target seems to have been set at $14.00 for Pacific Biosciences. Pacific Biosciences earned $0.31 in the first quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.14 and a 52-week-low of $3.85. Pacific Biosciences closed at $12.03 at the end of the last trading period.
With an Overweight rating, Barclays initiated coverage on 10x Genomics Inc (NASDAQ:TXG). The price target seems to have been set at $65.00 for 10x Genomics. 10x Genomics earned $0.44 in the first quarter, compared to $0.38 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.22 and a 52-week-low of $23.85. 10x Genomics closed at $53.23 at the end of the last trading period.
UBS initiated coverage on Hess Midstream LP (NYSE:HESM) with a Buy rating. The price target for Hess Midstream is set to $37.00. For the first quarter, Hess Midstream had an EPS of $0.47, compared to year-ago quarter EPS of $0.49. At the moment, the stock has a 52-week-high of $34.94 and a 52-week-low of $24.34. Hess Midstream closed at $28.42 at the end of the last trading period.
UBS initiated coverage on Antero Midstream Corp (NYSE:AM) with a Buy rating. The price target for Antero Midstream is set to $14.00. In the first quarter, Antero Midstream showed an EPS of $0.21, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.61 and a 52-week-low of $8.57. Antero Midstream closed at $10.47 at the end of the last trading period.
With a Buy rating, DA Davidson initiated coverage on JFrog Ltd (NASDAQ:FROG). The price target seems to have been set at $25.00 for JFrog. JFrog earned $0.06 in the first quarter, compared to $0.00 in the year-ago quarter. The stock has a 52-week-high of $27.96 and a 52-week-low of $16.42. At the end of the last trading period, JFrog closed at $21.51.
DA Davidson initiated coverage on GitLab Inc (NASDAQ:GTLB) with a Neutral rating. The price target for GitLab is set to $30.00. GitLab earned $0.03 in the fourth quarter, compared to $0.16 in the year-ago quarter. The current stock performance of GitLab shows a 52-week-high of $70.91 and a 52-week-low of $26.24. Moreover, at the end of the last trading period, the closing price was at $31.08.
